NEWSWIRE

...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The Abricot banana pudding clafoutis aux cerises chocolat pancake confiture à la fraise National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The Abricot banana pudding clafoutis aux cerises chocolat pancake confiture à la fraise National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
...
Alzheimer’s disease represents an epidemic sized threat to China, which already has the largest population of sufferers from the disease. The initiation of the global BRAIN Initiative reflects concerns at the lack of progress in an area of medicine that has turned into a graveyard for pharmaceutical companies’ drug development efforts over the last...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The Abricot banana pudding clafoutis aux cerises chocolat pancake confiture à la fraise National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
Fuan Pharmaceutical (Group) Co., Ltd., (SHE: 300194) has announced it has filed a clinical trial application with Chongqing local Food and Drug Administration for erlotinib API and tablets, along with its subsidiary Chongqing Qingyutang Pharma a ...
Hebei's provincial Health and Family Planning Commission (HFPC) is planning to introduce instant reimbursements for patients within the New Rural Cooperative Medical Scheme (NRCMS) by the end the November this year. The plan will also see greate ...
Most read
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
Yesterday's spotlight
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...
The National Administration of Drugs and Medical Devices (ANMAT) has approved of the sale of Signitor (pasireotide), the first and only drug designed especifically to treat Cushing's desease, an hormonal disorde...

200,000 more specialities available

Subscribe to a Premium Account :